Affiliation:
1. AKDENİZ ÜNİVERSİTESİ, TIP FAKÜLTESİ
Abstract
Objective
It was aimed to examine the socio-demographic
and clinical data of patients treated with Repetitive
Transcranial Magnetic Stimulation (rTMS) for
depressive disorder and to evaluate the relationship of
these data with remission response to rTMS treatment.
Material and Method: The medical records of 120
patients were evaluated retrospectively. Hamilton
Depression Scale (HAM-D), Beck Anxiety Scale (BAI),
and Richard-Campbell Sleep Scale (RCSQ) scores
were analyzed.
Results
60% (72/120) of the patients were women and the
mean age was 42.80±12.80 years. According to
the HAM-D scores (7 and below), 41.4% (46/111)
of the patients were in remission at the end of the
treatment. In addition, when the pre-treatment and
post-treatment scale scores were evaluated, HAM-D
scores and BAI scores decreased significantly after
treatment (respectively; p
Publisher
Medical Journal of Suleyman Demirel University
Reference28 articles.
1. 1. World Health Organization. Depressive disorder (depression)
[Internet]. WHO. [cited 18.08.2023]. Available from: https://
www.who.int/news-room/fact-sheets/detail/depression
2. 2. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan
KR, et al. Mood disorders in the medically ill: scientific review
and recommendations. Biol Psychiatry 2005; 58(3):175-89.
3. 3. Kverno KS, Mangano E. Treatment-Resistant Depression: Approaches to Treatment. J Psychosoc Nurs Ment Health Serv
2021; 59(9):7-11.
4. 4. Dowd SM, Rado J, Welch MJ, Janicak PG. Transcranial magnetic
stimulation for depression. Current Psychiatry 2008; 7(12):27-31.
5. 5. Yaşar AU, Cinemre B, Erdoğan A. Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Comorbid Nicotine Addiction with Major Depressive Disorder and Obsessive-
Compulsive Disorder. Bağımlılık Dergisi 2022; 23(3):1-1.
doi: 10.51982/bagimli.1016942.